PATENT CLAIM ANALYSIS

Application Number: 15982141
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "133100"]

Abstract:
The present disclosure relates to compositions and methods of use comprising antibodies or binding fragments thereof further comprising universal Fc glycoforms.

Claim (Index 5):
The isolated antibody or antigen-binding fragment of  claim 4  wherein the antibody or the antigen binding fragment further comprising H-FR1, H-FR2, H-FR3, and HFR4 selected from (i)-(iv):\n (i) H-FR1 selected from SEQ ID NO:159 (QVQLKESGPGLVAPSQSLSITCTVS); \n (ii) H-FR2 selected from SEQ ID NO:160 (VSWIRQPPGKGLEWIGV); \n (iii) H-FR3 selected from SEQ ID NO:161 (NYHSVLISRLTISKDNSKSQVFLKLNSLQTDDTATYYC); \n (iv) H-FR4 selected from SEQ ID NO:162 (WGQGTLVTVSS); respectively; \n and comprising L-FR1, L-FR2, L-FR3 and L-FR4 selected from (v)-(viii): \n (v) L-FR1 selected from SEQ ID NO: 155 (QIVLTQSPAIMSASPGEKVTMTCSAS); \n (vi) L-FR2 selected from SEQ ID NO:156 (MHWYQQKSGTSPKRWIY); \n (vii) L-FR3 selected from SEQ ID NO: 157 (KLSSGVPGRFSGSGSGTSYSLTISRLEAEDAATYYC); \n (viii) L-FR4 selected from SEQ ID NO: 158 (FGGGTKVEIKR); respectively.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 93.0
- Lexical Diversity: 1.04762
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15011544', '15011543', '14798312', '14599174', '15683685']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7172140477907232
- 35 USC 102 Novelty (BERT): 0.7019069703601243
- Combined Prediction Score: 0.7156833400476633
- Mean Citation Score: 611.699212
- Max Citation Score: 860.38965
- Similarity Product: 727.3880562692642

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test